Position
CERTUITY, LLC in Ascendis Pharma A/S
Back to the book · All holders of ASND
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $18.1K$213.24 → $228.73
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.17K | $249.5K | — | — | — | 0.0% |
| Q1 2026 | 1.17K | $267.6K | $228.73 | $18.1K | −$0 | 0.0% |